[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 32 of about 32
1. Azoulay S, Laé M, Fréneaux P, Merle S, Al Ghuzlan A, Chnecker C, Rosty C, Klijanienko J, Sigal-Zafrani B, Salmon R, Fourquet A, Sastre-Garau X, Vincent-Salomon A: KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol; 2005 Dec;18(12):1623-31
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome.
  • Recent biological studies have classified breast carcinomas into HER2-overexpressing, estrogen receptor-positive/luminal, basal- and normal-like groups.
  • According to this new biological classification, the objectives of our study were to assess the clinical, morphologic and immunophenotypic characteristics of adenoid cystic carcinoma of the breast in order to classify this subtype of breast carcinoma.
  • A total of 18 cases of adenoid cystic carcinoma were identified from the Institut Curie files.
  • Our study shows that adenoid cystic carcinoma of the breast is a special, estrogen receptor, progesterone receptor, HER-2 negative and highly KIT-positive, basal-like breast carcinoma, associated with an excellent prognosis.
  • This highly specific immunophenotype could be useful to differentiate adenoid cystic carcinoma of the breast from other subtypes of breast carcinoma such as cribriform carcinoma.
  • [MeSH-major] Breast Neoplasms / metabolism. Carcinoma, Adenoid Cystic / metabolism. Proto-Oncogene Proteins c-kit / metabolism

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16258515.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 68238-35-7 / Keratins; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 2.7.10.1 / Receptor, ErbB-2
  •  go-up   go-down


2. Pandya AN, Shah P, Patel R, Patel PR: Adenoid cystic carcinoma of breast and the importance of differentiation from collagenous spherulosis by FNAC. J Cytol; 2010 Apr;27(2):69-70

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic carcinoma of breast and the importance of differentiation from collagenous spherulosis by FNAC.
  • We are presenting a case of adenoid cystic carcinoma (ACC) of breast in a 66-year-old woman having lump in left breast, admitted to surgical ward of our institute.
  • A diagnosis of ACC of breast was made and subsequently confirmed histopathologically and on immunohistochemistry.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21157554.001).
  • [ISSN] 0974-5165
  • [Journal-full-title] Journal of cytology
  • [ISO-abbreviation] J Cytol
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3001180
  • [Keywords] NOTNLM ; Adenoid cystic carcinoma / FNAC / breast, collagenous spherulosis
  •  go-up   go-down


3. Mastropasqua MG, Maiorano E, Pruneri G, Orvieto E, Mazzarol G, Vento AR, Viale G: Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast. Mod Pathol; 2005 Oct;18(10):1277-82
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast.
  • Adenoid cystic carcinoma of the breast represents a unique clinicopathologic entity with a variable histological appearance and a relatively indolent clinical course in most of the cases.
  • Adenoid cystic carcinoma may be difficult to differentiate from infiltrating duct carcinomas, and in particular from tubular and cribriform carcinomas, especially in core or vacuum-assisted biopsies.
  • We evaluated the prevalence of c-kit, p63, and e-cadherin immunoreactivity in a series of 20 adenoid cystic carcinomas, comparing the results with those obtained in a series of infiltrating tubular carcinomas and infiltrating cribriform carcinomas.
  • Three (15%) adenoid cystic carcinomas and all infiltrating tubular and cribriform carcinomas showed estrogen receptor and/or progesterone receptor immunoreactivity (P < 0.00001 for estrogen and P = 0.00002 for progesterone receptors).
  • Adenoid cystic carcinomas consistently lacked any immunoreactivity for HER/2, whereas three (15%) infiltrating and cribriform carcinomas showed weak and incomplete membrane staining (P = 0.23077).
  • Membranous immunoreactivity for c-kit was found in all except one (predominantly basaloid) adenoid cystic carcinomas (95%), and in none of the infiltrating tubular and cribriform carcinomas (P < 0.00001).
  • Nuclear immunoreactivity for p63 was found in all except three (predominantly basaloid) adenoid cystic carcinomas (85%) and in none of the infiltrating tubular and cribriform carcinomas (P < 0.00001).
  • All infiltrating tubular and cribriform carcinomas and 18/20 (90%) adenoid cystic carcinomas showed immunoreactivity for e-cadherin (P = 0.48718).
  • In summary, adenoid cystic carcinomas showed the following phenotype: estrogen receptor-/progesterone receptor-/c-kit+/p63+ (13 cases, 65%), estrogen receptor-/progesterone receptor/c-kit+/p63- (three cases, 15%), estrogen receptor-/progesterone receptor-/c-kit-/p63+ (one case, 5%), estrogen receptor+/progesterone receptor+/c-kit+/p63+ (two cases, 10%), and estrogen receptor+/progesterone receptor-/c-kit+/p63+ (one case).
  • Our data provide evidence that immunoreactivity for c-kit and/or p63 may be useful in differentiating adenoid cystic carcinomas from other types of breast cancer.
  • [MeSH-major] Breast Neoplasms / diagnosis. Carcinoma, Adenoid Cystic / metabolism. Membrane Proteins / metabolism. Proto-Oncogene Proteins c-kit / metabolism

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15846389.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CKAP4 protein, human; 0 / Cadherins; 0 / Membrane Proteins; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


Advertisement
4. Crisi GM, Marconi SA, Makari-Judson G, Goulart RA: Expression of c-kit in adenoid cystic carcinoma of the breast. Am J Clin Pathol; 2005 Nov;124(5):733-9
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of c-kit in adenoid cystic carcinoma of the breast.
  • Breast adenoid cystic carcinoma (BACC) is a biologically distinct tumor with morphologic mimickers, which might make accurate classification problematic.
  • Because c-kit expression has been reported in adenoid cystic carcinoma of various anatomic sites, we evaluated BACC for c-kit by immunohistochemical analysis, comparing the findings to similarly stained mimickers.
  • Tested cases included 6 BACCs, 15 low-grade infiltrating ductal carcinomas (LGIDCs) chosen as potential mimickers, and 15 head-neck adenoid cystic carcinomas (HNACCs).
  • Immunohistochemical evaluation for c-kit might aid in accurately classifying carcinomas with histologic features overlapping adenoid cystic carcinoma and LGIDC.
  • [MeSH-major] Breast Neoplasms / chemistry. Carcinoma, Adenoid Cystic / chemistry. Proto-Oncogene Proteins c-kit / analysis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carcinoma, Ductal, Breast / chemistry. Carcinoma, Ductal, Breast / pathology. Female. Humans. Immunohistochemistry. Middle Aged

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16203286.001).
  • [ISSN] 0002-9173
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


5. Njeze GE: Adenoid cystic carcinoma of the breast at Enugu Nigeria. Niger J Clin Pract; 2007 Mar;10(1):70-3
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic carcinoma of the breast at Enugu Nigeria.
  • BACKGROUND: (Adenoid cystic carcinoma (ACC) of the breast is a rare type of neoplasm that is histologically indistinguishable from other examples in other sites and generally has a good prognosis).
  • PATIENTS AND METHODS: Case notes of breast cancer patients stored in the medical records department were retrospectively reviewed with a view to studying those with ACC.
  • RESULT: Adenoid cystic carcinoma of the breast was diagnosed in 9 out of 222 patients treated for cancer of the breast, from 1995-2000.
  • A lump in the breast led to the initial suspicion of a tumor.
  • Some of them had pain in the breast.
  • [MeSH-major] Breast Neoplasms / diagnosis. Carcinoma, Adenoid Cystic / diagnosis. Treatment Outcome

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17668719.001).
  • [ISSN] 1119-3077
  • [Journal-full-title] Nigerian journal of clinical practice
  • [ISO-abbreviation] Niger J Clin Pract
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nigeria
  •  go-up   go-down


6. Sheen-Chen SM, Eng HL, Chen WJ, Cheng YF, Ko SF: Adenoid cystic carcinoma of the breast: truly uncommon or easily overlooked? Anticancer Res; 2005 Jan-Feb;25(1B):455-8
MedlinePlus Health Information. consumer health - Mammography.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic carcinoma of the breast: truly uncommon or easily overlooked?
  • BACKGROUND: Adenoid cystic carcinoma of the breast is an uncommon histologic form of breast cancer, comprising in most series less than 1% of all mammary cancers.
  • No obvious palpable mass of breast was found on physical examination.
  • Mammography showed a small well-defined nodule in the medial part of the left breast without mammographic evidence of malignancy.
  • Ultrasonography showed a 1.5 cm nodule with well-defined margin and heterogenous echogenicity in the medial part of the left breast.
  • The final pathological report was adenoid cystic carcinoma.
  • No obvious palpable mass of breast was found on physical examination.
  • Mammography showed dense mammary tissue with no mammographic evidence of malignancy.
  • Ultrasonography showed two contiguous well-defined nodules with heterogenous echogenicity in the upper, middle part of the left breast.
  • Histopathological examination showed typical features of an adenoid cystic carcinoma.
  • CONCLUSION: Adenoid cystic carcinoma of the breast fails to show the typical appearance of invasive ductal carcinoma on both mammogram and ultrasonography, probably due to its relatively well-defined nature with less surrounding architectural disruption and fibrosis.
  • Hence a "negative" finding or a benign-looking breast lesion on mammography cannot completely exclude the existence of this disease.
  • The presence of a painful breast lesion without obvious inflammatory evidence while compressed is a meaningful clue, which should lead to the suspicion of adenoid cystic carcinoma of the breast.
  • [MeSH-major] Breast Neoplasms / diagnosis. Carcinoma, Adenoid Cystic / diagnosis. Mammography / methods
  • [MeSH-minor] Aged. Breast / pathology. Female. Humans. Image Processing, Computer-Assisted. Pain. Ultrasonography, Mammary / methods

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15816611.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


7. Ghabach B, Anderson WF, Curtis RE, Huycke MM, Lavigne JA, Dores GM: Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study. Breast Cancer Res; 2010;12(4):R54
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study.
  • INTRODUCTION: Adenoid cystic carcinoma of the breast (breast-ACC) is a rare and special type of basal-like tumor for which scant population-based descriptive data exist.
  • We sought to provide new population-based information on breast-ACC incidence, relative survival, and associated cancer risk in the United States.
  • METHODS: Using data from the Surveillance, Epidemiology and End Results Program, we calculated age-adjusted incidence rates (IRs), IR ratios (IRRs), and relative survival for breast-ACC, and standardized incidence ratios (SIRs) for other cancers.
  • RESULTS: Overall 338 women (IR = 0.92/1 million person-years) were diagnosed with breast-ACC during 1977 to 2006.
  • The risk of female breast cancer was not increased following (SIR = 0.89, 95% confidence interval = 0.43 to 1.64) or preceding (SIR = 0.71, 95% confidence interval = 0.28 to 1.46) breast-ACC.
  • Similarly, no association was observed for breast-ACC and risk of all other cancers combined, solid tumors, or lymphohematopoietic malignancies.
  • CONCLUSIONS: Breast-ACC among women is characterized by ER-negative/PR-negative expression, rare regional lymph node involvement, a favorable prognosis with excellent survival, and absence of associated cancers.
  • These findings reinforce the importance of tailored treatments for breast-ACC and lend credence to the apparent heterogeneity of basal-like breast cancers.

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pol Med J. 1970;9(5):1140-8 [4324184.001]
  • [Cites] Pathol Eur. 1970;5(3):357-64 [4320056.001]
  • [Cites] J Clin Pathol. 1975 Aug;28(8):647-55 [171285.001]
  • [Cites] Surg Gynecol Obstet. 1979 Feb;148(2):240-2 [217114.001]
  • [Cites] J Natl Med Assoc. 1979 Apr;71(4):329-30 [220431.001]
  • [Cites] Hum Pathol. 1982 Oct;13(10):916-24 [6290368.001]
  • [Cites] Cancer. 1983 Aug 15;52(4):680-6 [6305483.001]
  • [Cites] Am J Clin Pathol. 1984 Mar;81(3):297-307 [6322567.001]
  • [Cites] Surg Neurol. 1986 Nov;26(5):470-2 [3020724.001]
  • [Cites] Ann Surg. 1987 Mar;205(3):295-301 [3030200.001]
  • [Cites] Cancer. 1987 Oct 1;60(7):1589-98 [2441847.001]
  • [Cites] Hum Pathol. 1987 Dec;18(12):1276-81 [2824330.001]
  • [Cites] Pathol Annu. 1989;24 Pt 2:237-54 [2549491.001]
  • [Cites] Arch Surg. 1992 Feb;127(2):233-5 [1311551.001]
  • [Cites] Am J Epidemiol. 1995 Feb 15;141(4):300-4 [7840107.001]
  • [Cites] Mod Pathol. 1996 Mar;9(3):215-9 [8685217.001]
  • [Cites] Am J Surg Pathol. 1998 May;22(5):569-75 [9591727.001]
  • [Cites] AJR Am J Roentgenol. 1998 Dec;171(6):1679-83 [9843312.001]
  • [Cites] Histopathology. 1999 Sep;35(3):241-8 [10469216.001]
  • [Cites] Dis Chest. 1957 Mar;31(3):324-7 [13404914.001]
  • [Cites] Breast Cancer Res Treat. 2004 Oct;87(3):225-32 [15528965.001]
  • [Cites] J Clin Oncol. 2004 Nov 15;22(22):4514-22 [15542802.001]
  • [Cites] Anticancer Res. 2005 Jan-Feb;25(1B):455-8 [15816611.001]
  • [Cites] Am J Clin Pathol. 2005 Jun;123(6):866-73 [15899777.001]
  • [Cites] Mod Pathol. 2005 Oct;18(10):1277-82 [15846389.001]
  • [Cites] Am J Clin Pathol. 2005 Nov;124(5):733-9 [16203286.001]
  • [Cites] Cancer. 2005 Oct 15;104(8):1733-41 [16138363.001]
  • [Cites] Mod Pathol. 2005 Dec;18(12):1623-31 [16258515.001]
  • [Cites] Breast Cancer. 2006;13(1):112-6 [16518072.001]
  • [Cites] J Ultrasound Med. 2006 Jul;25(7):921-4 [16798905.001]
  • [Cites] Mod Pathol. 2006 Oct;19(10):1351-7 [16810311.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1899-905 [17035397.001]
  • [Cites] Breast J. 2007 Mar-Apr;13(2):206 [17319868.001]
  • [Cites] J Clin Oncol. 2007 Sep 1;25(25):3923-9 [17679726.001]
  • [Cites] Breast Cancer Res. 2007;9(5):R65 [17910759.001]
  • [Cites] Curr Opin Obstet Gynecol. 2008 Feb;20(1):40-6 [18197004.001]
  • [Cites] Can J Surg. 2008 Apr;51(2):E36-7 [18377738.001]
  • [Cites] Pathology. 2008 Jun;40(4):413-5 [18446636.001]
  • [Cites] J Pathol. 2008 Oct;216(2):141-50 [18720457.001]
  • [Cites] Virchows Arch. 2009 Jan;454(1):107-14 [19031084.001]
  • [Cites] Singapore Med J. 2009 Jan;50(1):e8-11 [19224074.001]
  • [Cites] Arch Intern Med. 2009 May 25;169(10):999-1000, author reply 1000-1 [19468099.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2214-20 [19661080.001]
  • [Cites] J Clin Pathol. 2010 Mar;63(3):220-8 [20203221.001]
  • [Cites] Breast Cancer. 2001;8(1):84-9 [11180772.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74 [11553815.001]
  • [Cites] Breast J. 2002 Jan-Feb;8(1):53-4 [11856164.001]
  • [Cites] Am J Surg Pathol. 2002 Apr;26(4):413-20 [11914618.001]
  • [Cites] Cancer. 2002 Apr 15;94(8):2119-27 [12001107.001]
  • [Cites] Am J Surg. 2002 Jun;183(6):646-9 [12095593.001]
  • [Cites] Breast. 2003 Feb;12(1):75-7 [14659359.001]
  • [Cites] Semin Diagn Pathol. 2003 Nov;20(4):279-304 [14694981.001]
  • [Cites] Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):178-83 [14734467.001]
  • [Cites] Pathology. 2004 Aug;36(4):362-4 [15370139.001]
  • [Cites] Surg Gynecol Obstet. 1966 Jun;122(6):1289-94 [5941852.001]
  • [Cites] Ann Surg. 1967 Nov;166(5):861-4 [6057095.001]
  • [Cites] Cancer. 1969 Oct;24(4):740-5 [4309694.001]
  • [Cites] Am J Clin Pathol. 1970 Sep;54(3):419-25 [4319210.001]
  • [Cites] Am J Clin Pathol. 1973 May;59(5):653-8 [4349849.001]
  • (PMID = 20653964.001).
  • [ISSN] 1465-542X
  • [Journal-full-title] Breast cancer research : BCR
  • [ISO-abbreviation] Breast Cancer Res.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2949643
  •  go-up   go-down


8. Law YM, Quek ST, Tan PH, Wong SL: Adenoid cystic carcinoma of the breast. Singapore Med J; 2009 Jan;50(1):e8-11
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic carcinoma of the breast.
  • Adenoid cystic carcinoma of the breast is a rare neoplasm that constitutes less than one percent of all mammary carcinomas.
  • In contrast to the aggressive nature of adenoid cystic carcinoma that occurs in the head and neck region, adenoid cystic carcinoma of the breast has a very favourable prognosis.
  • We describe a 63-year-old woman with adenoid cystic carcinoma detected on mammography in our national breast screening programme, the radiological findings at presentation, the surgical management and a review of the literature.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Adenoid Cystic / pathology
  • [MeSH-minor] Combined Modality Therapy. Diagnosis, Differential. Female. Humans. Mammography. Middle Aged

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19224074.001).
  • [ISSN] 0037-5675
  • [Journal-full-title] Singapore medical journal
  • [ISO-abbreviation] Singapore Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Singapore
  • [Number-of-references] 11
  •  go-up   go-down


9. Da Silva L, Buck L, Simpson PT, Reid L, McCallum N, Madigan BJ, Lakhani SR: Molecular and morphological analysis of adenoid cystic carcinoma of the breast with synchronous tubular adenosis. Virchows Arch; 2009 Jan;454(1):107-14
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular and morphological analysis of adenoid cystic carcinoma of the breast with synchronous tubular adenosis.
  • Adenoid cystic carcinoma (ACC) of the breast is a rare tumour.
  • Its recognition as a special type of breast carcinoma is very important because its prognosis is better than the not-otherwise-specified invasive ductal carcinoma and its treatment may not include axillary dissection.
  • Tubular adenosis (TA) is a very rare condition of the breast that is histologically benign; however, it has been described in association with invasive ductal carcinoma.
  • There are scant data regarding the molecular genomic alterations in ACC of the breast and no data has been presented on TA.
  • Herein, we provide a morphological characterisation of TA arising synchronically with ACC in the breast.
  • [MeSH-major] Breast Neoplasms / complications. Breast Neoplasms / pathology. Carcinoma, Adenoid Cystic / complications. Carcinoma, Adenoid Cystic / pathology. Fibrocystic Breast Disease / complications. Fibrocystic Breast Disease / pathology
  • [MeSH-minor] Actins / metabolism. Breast / metabolism. Breast / pathology. Cell Proliferation. DNA, Neoplasm. Female. Genomic Instability / genetics. Humans. Keratin-19 / metabolism. Keratin-7 / metabolism. Middle Aged. S100 Proteins / metabolism

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19031084.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Actins; 0 / DNA, Neoplasm; 0 / Keratin-19; 0 / Keratin-7; 0 / S100 Proteins
  •  go-up   go-down


10. Coates JM, Martinez SR, Bold RJ, Chen SL: Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol; 2010 Sep 15;102(4):342-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast.
  • BACKGROUND: The role of adjuvant radiation therapy (RT) for adenoid cystic carcinoma (ACC) of the breast remains unclear.
  • MATERIALS AND METHODS: We queried the Surveillance, Epidemiology, and End Results database for patients with breast ACC resected between 1988 and 2005, and divided patients based on the receipt of RT.
  • CONCLUSIONS: RT after local surgical therapy for ACC of the breast improved both cause-specific and overall survival.
  • [MeSH-major] Breast Neoplasms / radiotherapy
  • [MeSH-minor] Carcinoma, Adenoid Cystic / mortality. Carcinoma, Adenoid Cystic / pathology. Carcinoma, Adenoid Cystic / radiotherapy. Female. Humans. Middle Aged. Neoplasm Staging. Radiotherapy, Adjuvant

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Wiley-Liss, Inc.
  • (PMID = 20589709.001).
  • [ISSN] 1096-9098
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Vranić S, Bilalović N, Lee LM, Kruslin B, Lilleberg SL, Gatalica Z: PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney. Hum Pathol; 2007 Sep;38(9):1425-31
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney.
  • Adenoid cystic carcinoma (ACC) of the breast rarely metastasizes and has been associated with excellent prognosis.
  • We describe a patient with renal metastasis of primary breast ACC 5 years after the mastectomy.
  • [MeSH-major] Biomarkers, Tumor / genetics. Breast Neoplasms / pathology. Cystadenocarcinoma / secondary. Kidney Neoplasms / secondary. Mutation. PTEN Phosphohydrolase / genetics. Phosphatidylinositol 3-Kinases / genetics


12. Falchook GS, Wheler JJ, Tannir NM, Naing A, Jackson E, Hong D, Lawhorn KN, Ng C, Amin H, Kurzrock R: Hypoxia-inducible factor-1α (HIF-1α) modulation in combination with anti-angiogenic therapy. J Clin Oncol; 2009 May 20;27(15_suppl):3555

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two partial responses were observed in patients with renal cell carcinoma (RCC) (Total patients with RCC = 6).
  • Minor responses or stable disease lasting ≥4 months was achieved in 8 patients, including RCC (1), breast (1), leiomyosarcoma (1), nasopharyngeal (2), hepatocellular (1), neuroendocrine (1), lacrimal gland adenocystic carcinoma (1).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961363.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Kallel R, Bahri Zouari I, Gouiaa N, Charfi S, Daoud E, Ayadi L, Makni S, Daoud J, Sellami Boudawara T: [Adenoid cystic carcinoma of the breast]. Cancer Radiother; 2009 Jul;13(4):323-8
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenoid cystic carcinoma of the breast].
  • [Transliterated title] Carcinome adénoïde kystique du sein.
  • Adenoid cystic carcinoma of the breast is a rare neoplasm, accounting for only 0.1% of all malignant breast tumours.
  • The preoperative diagnosis is possible with fine-needle aspiration cytology.
  • The diagnosis is made by histological examination, presented a difficult differential diagnosis with cribriform carcinoma; so it is necessary to use histochemical or immunohistochemical techniques.
  • Compared to other locations, adenoid cystic carcinoma of the breast has a favorable prognosis.
  • The aim of our study is to describe the epidemiological, clinicopathological characteristics, the treatment and the prognosis of this rare type of breast tumour.
  • [MeSH-major] Breast Neoplasms. Carcinoma, Adenoid Cystic
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Combined Modality Therapy / methods. Diagnosis, Differential. Female. Humans. Middle Aged. Young Adult

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19464219.001).
  • [ISSN] 1769-6658
  • [Journal-full-title] Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
  • [ISO-abbreviation] Cancer Radiother
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 30
  •  go-up   go-down


14. Albores-Saavedra J, Heard SC, McLaren B, Kamino H, Witkiewicz AK: Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast. Am J Clin Pathol; 2005 Jun;123(6):866-73
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast.
  • We compared 4 breast cylindromas with 50 dermal cylindromas and 8 adenoid cystic breast carcinomas.
  • Except for a modest increase in the number of eccrine ducts and reactive Langerhans cells in dermal cylindromas, breast and dermal cylindromas showed identical histologic and immunohistochemical features.
  • Clusters of sebaceous cells and a few eccrine ducts are described in breast cylindromas.
  • Cytokeratin 7 labeled predominantly the central basaloid cells, and smooth muscle actin stained peripheral myoepithelial cells in breast and dermal cylindromas.
  • Cylindromas of the breast and skin did not express cytokeratin 20, gross cystic disease fluid protein 15, or estrogen or progesterone receptor.
  • Breast cylindroma might be confused with the solid variant of adenoid cystic carcinoma, especially in needle core biopsy specimens, because they share nodular and trabecular patterns, basaloid cells, myoepithelial cells, eccrine ducts, and hyaline globules of basement membrane material.
  • However, adenoid cystic carcinoma displays an infiltrative growth pattern, cytologic atypia, and mitotic figures and lacks the continuous, thickened basement membrane.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Adenoid Cystic / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Aged. Biomarkers, Tumor / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Middle Aged. Sweat Glands / pathology

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15899777.001).
  • [ISSN] 0002-9173
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


15. Sbitti Y, Kadiri H, Fetohi M, Elghissassi I, M'rabti H, Boutayeb S, Ichou M, Boussen H, Errihani H: [Primary adenoid cystic carcinoma in breast]. Cancer Radiother; 2009 Jan;13(1):65-8
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary adenoid cystic carcinoma in breast].
  • [Transliterated title] Carcinome adénoïde kystique primitif du sein.
  • Adenoid cystic carcinoma (ACC) of the breast is a rare neoplasm.
  • Clinical examination showed limited painful breast nodules.
  • Diagnosis was based on final histopathological exam completed by immunohistochemistry or after slides review.
  • [MeSH-major] Breast Neoplasms. Carcinoma, Adenoid Cystic
  • [MeSH-minor] Aged. Female. Humans. Immunohistochemistry. Lymph Node Excision. Mammography. Mastectomy. Middle Aged. Physical Examination. Postoperative Care / methods. Prognosis. Radiotherapy, Adjuvant. Rare Diseases. Treatment Outcome. Tunisia. Ultrasonography, Mammary

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19097926.001).
  • [ISSN] 1278-3218
  • [Journal-full-title] Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
  • [ISO-abbreviation] Cancer Radiother
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 18
  •  go-up   go-down


16. Franceschini G, Terribile D, Scafetta I, Magno S, Fabbri C, Chiesa F, Di Leone A, Moschella F, Scaldaferri A, Fragomeni S, Vellone V, Mulè A, Masetti R: Conservative treatment of a rare case of multifocal adenoid cystic carcinoma of the breast: case report and literature review. Med Sci Monit; 2010 Mar;16(3):CS33-39
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conservative treatment of a rare case of multifocal adenoid cystic carcinoma of the breast: case report and literature review.
  • BACKGROUND: Adenoid cystic carcinoma of the breast is a rare neoplasm accounting for 0.1% of all malignant breast tumors and presenting most commonly as a painful breast mass.
  • Compared with the more common histological forms of breast cancer, it has a more favorable prognosis and lymph node involvement or distant metastases seldom occur.
  • CASE REPORT: A unique case of multifocal adenoid cystic carcinoma of the breast presenting as a painful and well-defined lump and treated with conservative surgery with adjuvant radiotherapy is reported.
  • A breast-conserving approach may be recommended even if mastectomy has been traditionally the treatment of choice.
  • The authors found no other reports in the literature focusing on a conservative approach to multifocal adenoid cystic carcinoma.
  • [MeSH-major] Breast Neoplasms / therapy. Carcinoma, Adenoid Cystic / therapy

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20190690.001).
  • [ISSN] 1643-3750
  • [Journal-full-title] Medical science monitor : international medical journal of experimental and clinical research
  • [ISO-abbreviation] Med. Sci. Monit.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 39
  •  go-up   go-down


17. Vranic S, Frkovic-Grazio S, Lamovec J, Serdarevic F, Gurjeva O, Palazzo J, Bilalovic N, Lee LM, Gatalica Z: Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification. Hum Pathol; 2010 Nov;41(11):1617-23
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification.
  • Adenoid cystic carcinoma of the breast is a rare subtype of breast cancer with basal-like features.
  • Published studies on breast adenoid cystic carcinoma are limited, resulting in relatively scarce information on the value of predictive tumor markers.
  • We studied 20 primary cases of adenoid cystic carcinoma of the breast for expression of estrogen receptor, progesterone receptor, androgen receptor, epidermal growth factor receptor, HER-2/neu, and topoisomerase IIα using immunohistochemistry and fluorescent in situ hybridization methods.
  • Our study shows that the majority of adenoid cystic carcinomas of the breast do not overexpress Her-2/neu, topoisomerase IIα, or estrogen receptor, and thus, they are unlikely to respond to therapies targeting these proteins.
  • However, these tumors frequently over-express epidermal growth factor receptor, indicating a potential benefit from anti-epidermal growth factor receptor therapy for patients with advanced adenoid cystic carcinomas of the breast.
  • [MeSH-major] Antigens, Neoplasm / metabolism. Breast Neoplasms, Male / metabolism. Carcinoma, Adenoid Cystic / metabolism. DNA Topoisomerases, Type II / metabolism. DNA-Binding Proteins / metabolism. Gene Amplification. Gene Expression Regulation, Neoplastic. Receptor, Epidermal Growth Factor / genetics

  • MedlinePlus Health Information. consumer health - Male Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20688355.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / DNA-Binding Proteins; EC 2.7.10.1 / EGFR protein, human; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; EC 5.99.1.3 / DNA Topoisomerases, Type II; EC 5.99.1.3 / DNA topoisomerase II alpha
  •  go-up   go-down


18. Rabban JT, Swain RS, Zaloudek CJ, Chase DR, Chen YY: Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers. Mod Pathol; 2006 Oct;19(10):1351-7
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers.
  • Adenoid cystic carcinoma of the breast is a rare neoplasm whose cribriform architecture may mimic invasive cribriform carcinoma, cribriform ductal carcinoma in situ, and collagenous spherulosis.
  • The diagnosis may be even more challenging in needle core biopsies.
  • Immunohistochemical expression of p63 and c-kit distinguishes adenoid cystic carcinoma from invasive cribriform carcinoma and ductal carcinoma in situ.
  • A formal comparison of the immunophenotype of adenoid cystic carcinoma to collagenous spherulosis has not been reported.
  • We evaluated smooth muscle actin, p63, calponin, smooth muscle myosin heavy chain, as well as c-kit, in nine cases of cribriform pattern adenoid cystic carcinoma of the breast in comparison to 12 cases of collagenous spherulosis.
  • Both entities strongly expressed p63 and smooth muscle actin; in adenoid cystic carcinoma, the basaloid myoepithelial-like tumor cells expressed these markers, but the ductular epithelial cells did not.
  • Neither calponin nor smooth muscle myosin heavy chain was expressed in adenoid cystic carcinoma but both were strongly expressed in collagenous spherulosis.
  • Whereas the ductular epithelial cells of adenoid cystic carcinoma were positive for c-kit in all cases, collagenous spherulosis was negative for c-kit.
  • Positive p63 expression by a cribriform breast lesion is not sufficiently specific to confirm a diagnosis of adenoid cystic carcinoma.
  • Reliance on p63 or smooth muscle actin alone poses a potential diagnostic pitfall in evaluating cribriform breast lesions.
  • [MeSH-major] Biomarkers, Tumor / analysis. Breast Neoplasms / pathology. Carcinoma, Adenoid Cystic / pathology. Collagen. Epithelial Cells / pathology
  • [MeSH-minor] Actins / analysis. Calcium-Binding Proteins / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Membrane Proteins / analysis. Microfilament Proteins / analysis. Myosin Heavy Chains / analysis. Proto-Oncogene Proteins c-kit / analysis. Retrospective Studies

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • Genetic Alliance. consumer health - Myoepithelial carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16810311.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Biomarkers, Tumor; 0 / CKAP4 protein, human; 0 / Calcium-Binding Proteins; 0 / Membrane Proteins; 0 / Microfilament Proteins; 0 / calponin; 9007-34-5 / Collagen; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 3.6.4.1 / Myosin Heavy Chains
  •  go-up   go-down


19. Hodgson NC, Lytwyn A, Bacopulos S, Elavathil L: Adenoid cystic breast carcinoma: high rates of margin positivity after breast conserving surgery. Am J Clin Oncol; 2010 Feb;33(1):28-31
MedlinePlus Health Information. consumer health - Mastectomy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic breast carcinoma: high rates of margin positivity after breast conserving surgery.
  • INTRODUCTION: Adenoid cystic carcinoma of the breast (ACCB) is a rare malignancy with favorable prognosis: axillary lymph node involvement, distant metastases, and death due to disease are uncommon.
  • METHODS: Pathology database searched to identify patients diagnosed with ACCB between 1988 and 2007 at Hamilton Health Sciences Centre, Hamilton, Ontario, Canada.Two pathologists independently reviewed histology to confirm diagnosis of ACCB, and documented surgical procedure, tumor size, tumor grade, surgical margin, and lymph node status.
  • Seven patients presented with a palpable mass and breast pain was described in 3.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Adenoid Cystic / pathology. Mastectomy. Mastectomy, Segmental. Neoplasm Recurrence, Local / pathology

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19730354.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Muslimani AA, Ahluwalia MS, Clark CT, Daw HA: Primary adenoid cystic carcinoma of the breast: case report and review of the literature. Int Semin Surg Oncol; 2006;3:17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary adenoid cystic carcinoma of the breast: case report and review of the literature.
  • Adenoid cystic carcinoma (ACC) of the breast is a rare neoplasm accounting for 0.1% of all breast carcinomas, and presenting most commonly as a painful breast mass.
  • In contrast to the aggressive nature of ACC at other sites, ACC of the breast has a favorable prognosis, lymph node involvement or distant metastases seldom occur.
  • We report a case of ACC of the breast managed with mastectomy and review the literature.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1970 Jan;25(1):186-98 [4312026.001]
  • [Cites] J Clin Pathol. 1975 Aug;28(8):647-55 [171285.001]
  • [Cites] Am J Clin Pathol. 1970 Sep;54(3):419-25 [4319210.001]
  • [Cites] Am J Clin Pathol. 1970 Jul;54(1):1-14 [4323423.001]
  • [Cites] Cancer. 2002 Apr 15;94(8):2119-27 [12001107.001]
  • [Cites] Breast. 2003 Feb;12(1):75-7 [14659359.001]
  • [Cites] Arch Surg. 1992 Feb;127(2):233-5 [1311551.001]
  • [Cites] Arch Pathol Lab Med. 1977 Jun;101(6):302-6 [193456.001]
  • [Cites] Hum Pathol. 1987 Dec;18(12):1276-81 [2824330.001]
  • [Cites] Diagn Cytopathol. 1993;9(2):184-7 [8390344.001]
  • [Cites] Diagn Cytopathol. 1996 Dec;15(5):431-4 [8989549.001]
  • [Cites] Am J Surg. 2002 Jun;183(6):646-9 [12095593.001]
  • (PMID = 16813652.001).
  • [ISSN] 1477-7800
  • [Journal-full-title] International seminars in surgical oncology : ISSO
  • [ISO-abbreviation] Int Semin Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1526742
  •  go-up   go-down


21. Biel MA: Photodynamic therapy of head and neck cancers. Methods Mol Biol; 2010;635:281-93
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The predominant histology is squamous cell carcinoma, but other histologies treated include mucosal melanoma, Kaposi's sarcoma, adenocarcinoma, metastatic breast carcinoma, and adenoid cystic carcinoma.

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20552353.001).
  • [ISSN] 1940-6029
  • [Journal-full-title] Methods in molecular biology (Clifton, N.J.)
  • [ISO-abbreviation] Methods Mol. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Glazebrook KN, Reynolds C, Smith RL, Gimenez EI, Boughey JC: Adenoid cystic carcinoma of the breast. AJR Am J Roentgenol; 2010 May;194(5):1391-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic carcinoma of the breast.
  • OBJECTIVE: The purpose of our study was to describe the imaging findings in adenoid cystic carcinoma (ACC) of the breast, with pathologic and clinical correlation.
  • MATERIALS AND METHODS: We retrospectively searched our surgical database from January 1994 through December 2008 for cases of pathologically proven ACC of the breast.
  • Of approximately 15,000 breast biopsies, 11,250 were malignant.
  • MRI (n = 5)--because of better soft-tissue contrast and dedicated, multiplanar breast sequences--helped show the extent of the tumor, particularly if dense breast tissue obscured the mass on CT.
  • On molecular breast imaging (n = 1), the tumors showed avid uptake of radiotracer but did not always show activity on PET (n = 1).
  • CONCLUSION: Recognition of ACC is important to avoid delay in diagnosis because this tumor has a good prognosis with rare metastases to axillary lymph nodes.
  • [MeSH-major] Breast Neoplasms / diagnosis. Breast Neoplasms / epidemiology. Carcinoma, Adenoid Cystic / diagnosis. Carcinoma, Adenoid Cystic / epidemiology. Magnetic Resonance Imaging / methods. Mammography / methods


23. Defaud-Hénon F, Tunon-de-Lara C, Fournier M, Marty M, Velasco V, de Mascarel I, MacGrogan G: [Adenoid cystic carcinoma of the breast: clinical, histological and immunohistochemical characterization]. Ann Pathol; 2010 Feb;30(1):7-16
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenoid cystic carcinoma of the breast: clinical, histological and immunohistochemical characterization].
  • [Transliterated title] Le carcinome adénoïde kystique du sein: étude clinique, histologique, immunohistochimique et revue de la littérature.
  • BACKGROUND: Adenoid cystic carcinoma (ACC) of the Breast is a rare tumour (less than 1 % of all breast carcinomas).
  • CONCLUSIONS: The mammary ACC is made of two cell types and is of good prognosis despite its triple negative phenotype, similar to the basal-like infiltrating carcinoma NOS.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Adenoid Cystic / pathology


24. de Luis E, Apesteguía L, Noguera JJ, Pina L, Martínez-Regueira F, Miguel C, Sáenz J: [Adenoid cystic carcinoma of the breast]. Radiologia; 2006 Jul-Aug;48(4):235-40
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenoid cystic carcinoma of the breast].
  • [Transliterated title] Carcinoma adenoide quístico de mama.
  • OBJECTIVE: To review the clinical presentation and imaging findings of adenoid cystic carcinoma (ACC).
  • MATERIAL AND METHODS: We performed a retrospective study of the period between January 1990 and July 2004, comprising five cases of ACC of the breast, all in women, among 4,036 malignant lesions diagnosed (0.12%).
  • Four patients remain asymptomatic at present (mean follow-up = 64 months) and one presented lung and liver metastes twelve years after the diagnosis of ACC.
  • CONCLUSION: ACC is an uncommon breast tumor with varied radiologic appearance, although moderately or highly suspicious lesions predominate.
  • [MeSH-major] Breast Neoplasms / diagnosis. Carcinoma, Adenoid Cystic / diagnosis

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17058651.001).
  • [ISSN] 0033-8338
  • [Journal-full-title] Radiología
  • [ISO-abbreviation] Radiologia
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


25. Mardi K, Sharma J, Garg R: Cytodiagnosis of adenoid cystic carcinoma of the breast. Indian J Pathol Microbiol; 2007 Jul;50(3):626-7
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytodiagnosis of adenoid cystic carcinoma of the breast.
  • [MeSH-major] Breast Neoplasms / diagnosis. Carcinoma, Adenoid Cystic / diagnosis

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17883166.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] India
  •  go-up   go-down


26. Alis H, Yigitbas H, Kapan S, Kalayci M, Kilic G, Aygun E: Multifocal adenoid cystic carcinoma of the breast: an unusual presentation. Can J Surg; 2008 Apr;51(2):E36-7
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multifocal adenoid cystic carcinoma of the breast: an unusual presentation.
  • [MeSH-major] Breast Neoplasms / surgery. Carcinoma, Adenoid Cystic / surgery
  • [MeSH-minor] Aged, 80 and over. Biopsy, Needle. Breast / pathology. Carcinoma, Ductal / diagnosis. Carcinoma, Ductal / pathology. Carcinoma, Ductal / surgery. Diagnosis, Differential. Female. Humans. Mammography. Mastectomy, Radical. Ultrasonography, Mammary

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Breast Cancer Res Treat. 2005 Oct;93(3):189-90 [16142443.001]
  • [Cites] Clin Lab Med. 2005 Dec;25(4):761-75, vii [16308090.001]
  • [Cites] Ann Diagn Pathol. 2005 Jun;9(3):157-9 [15944959.001]
  • [Cites] J Clin Pathol. 1989 May;42(5):470-6 [2543695.001]
  • [Cites] Breast. 2003 Feb;12(1):75-7 [14659359.001]
  • [Cites] Diagn Cytopathol. 2004 Apr;30(4):271-4 [15048965.001]
  • [Cites] Hum Pathol. 1987 Dec;18(12):1276-81 [2824330.001]
  • [Cites] Am J Surg. 2002 Jun;183(6):646-9 [12095593.001]
  • (PMID = 18377738.001).
  • [ISSN] 1488-2310
  • [Journal-full-title] Canadian journal of surgery. Journal canadien de chirurgie
  • [ISO-abbreviation] Can J Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Canada
  • [Other-IDs] NLM/ PMC2386339
  •  go-up   go-down


27. Grunert JH, Kreipe HH: [Morphologic and differential diagnosis of an adenoid-cystic carcinoma of the breast]. Rofo; 2007 Nov;179(11):1193-4
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Morphologic and differential diagnosis of an adenoid-cystic carcinoma of the breast].
  • [Transliterated title] Morphologie und Differenzialdiagnose des mammären adenoid-zystischen Karzinoms.
  • [MeSH-major] Breast Neoplasms / surgery. Breast Neoplasms / ultrasonography. Carcinoma, Adenoid Cystic / surgery. Carcinoma, Adenoid Cystic / ultrasonography
  • [MeSH-minor] Biomarkers / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Middle Aged

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17948198.001).
  • [ISSN] 1438-9029
  • [Journal-full-title] RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin
  • [ISO-abbreviation] Rofo
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers
  •  go-up   go-down


28. Youk JH, Kim MJ, Kim EK, Lee JY, Oh KK, Park BW: Recurrence of adenoid cystic carcinoma in the breast after lumpectomy and adjuvant therapy. J Ultrasound Med; 2006 Jul;25(7):921-4
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrence of adenoid cystic carcinoma in the breast after lumpectomy and adjuvant therapy.
  • [MeSH-major] Breast Neoplasms / therapy. Breast Neoplasms / ultrasonography. Carcinoma, Adenoid Cystic / therapy. Carcinoma, Adenoid Cystic / ultrasonography. Mastectomy, Segmental. Neoplasm Recurrence, Local / ultrasonography

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16798905.001).
  • [ISSN] 0278-4297
  • [Journal-full-title] Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
  • [ISO-abbreviation] J Ultrasound Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Torrão MM, da Costa JM, Ferreira E, da Silva MV, Paiva I, Lopes C: Adenoid cystic carcinoma of the breast. Breast J; 2007 Mar-Apr;13(2):206
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic carcinoma of the breast.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Adenoid Cystic / pathology
  • [MeSH-minor] Adult. Biopsy, Fine-Needle. Breast / pathology. Female. Humans

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17319868.001).
  • [ISSN] 1075-122X
  • [Journal-full-title] The breast journal
  • [ISO-abbreviation] Breast J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. Soon SR, Yong WS, Ho GH, Wong CY, Ho BC, Tan PH: Adenoid cystic breast carcinoma: a salivary gland-type tumour with excellent prognosis and implications for management. Pathology; 2008 Jun;40(4):413-5
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic breast carcinoma: a salivary gland-type tumour with excellent prognosis and implications for management.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Adenoid Cystic / pathology

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18446636.001).
  • [ISSN] 0031-3025
  • [Journal-full-title] Pathology
  • [ISO-abbreviation] Pathology
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


31. Page DL: Adenoid cystic carcinoma of breast, a special histopathologic type with excellent prognosis. Breast Cancer Res Treat; 2005 Oct;93(3):189-90
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic carcinoma of breast, a special histopathologic type with excellent prognosis.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Adenoid Cystic / pathology

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Breast Cancer Res Treat. 2004 Oct;87(3):225-32 [15528965.001]
  • (PMID = 16142443.001).
  • [ISSN] 0167-6806
  • [Journal-full-title] Breast cancer research and treatment
  • [ISO-abbreviation] Breast Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Comment; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


32. Sarnaik AA, Meade T, King J, Acs G, Hoover S, Cox CE, Carter WB, Laronga C: Adenoid cystic carcinoma of the breast: a review of a single institution's experience. Breast J; 2010 Mar-Apr;16(2):208-10
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoid cystic carcinoma of the breast: a review of a single institution's experience.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Adenoid Cystic / pathology

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20030648.001).
  • [ISSN] 1524-4741
  • [Journal-full-title] The breast journal
  • [ISO-abbreviation] Breast J
  • [Language] eng
  • [Publication-type] Letter; Review
  • [Publication-country] United States
  • [Number-of-references] 5
  •  go-up   go-down






Advertisement